Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 12 of 12 for “"passive immunotherapy"”.

  1. TOWARDS PASSIVE IMMUNOTHERAPY OF PANDEMIC INFLUENZA

    … CONVENTIONAL VACCINE STRATEGIES. COMBINATION PASSIVE IMMUNOTHERAPY USING NON-COMPETING NEUTRALIZING ANTIBODIES HAS BEEN PROPOSED AS A VIABLE ALTERNATIVE TO PROVIDE BROAD PROTECTION AGAINST DRIFT VARIANTS. THIS APPROACH NECESSITATES THE PRE-PANDEMIC PRODUCTION AND CHARACTERIZATION OF POTENTLY …

    nus Repository record for TOWARDS PASSIVE IMMUNOTHERAPY OF PANDEMIC INFLUENZA (opens in a new tab) Download file for TOWARDS PASSIVE IMMUNOTHERAPY OF PANDEMIC INFLUENZA (opens in a new tab)

  2. Production of recombinant Immunoglobulin A in plants for passive immunotherapy

    Mucosal passive immunization is the transfer of active antibodies from one organism to the mucosal surfaces of another organism for preventing or treating infectious diseases. Mucosal passive immunization has a great potential for the prevention and treatment of enteric infections like Rotavirus, …

    upv Repository record for Production of recombinant Immunoglobulin A in plants for passive immunotherapy (opens in a new tab)

  3. Novel active and passive immunotherapy regimens against nosocomial infections caused by multidrug resistant enterococci

    … pathogens responsible for nosocomial infections. Passive and active immunotherapies targeting capsular polysaccharides and surface-associated proteins have emerged as a potential prevention and/or treatment strategy against this opportunistically pathogenic bacterium. In the first part of this …

    lmu-germany Repository record for Novel active and passive immunotherapy regimens against nosocomial infections caused by multidrug resistant enterococci (opens in a new tab)

  4. Novel active and passive immunotherapy regimens against nosocomial infections caused by multidrug resistant enterococci

    … pathogens responsible for nosocomial infections. Passive and active immunotherapies targeting capsular polysaccharides and surface-associated proteins have emerged as a potential prevention and/or treatment strategy against this opportunistically pathogenic bacterium.In the first part of this …

    greece Repository record for Novel active and passive immunotherapy regimens against nosocomial infections caused by multidrug resistant enterococci (opens in a new tab)

  5. S100A1 and S100B: Novel Drug Targets for Alzheimer's Disease Therapy

    … utilizes two approaches, genetic ablation and passive immunotherapy, to inhibit S100A1 and/or S100B in the PSAPP AD mouse model to ascertain the net contribution of these proteins to AD pathology. In addition, a combination of microarray profiling, post-array validation and bioinformatics were …

    tamu Repository record for S100A1 and S100B: Novel Drug Targets for Alzheimer's Disease Therapy (opens in a new tab)

  6. Active and Adoptive Immunotherapy in Indolent Lymphoproliferative Diseases

    … its maintenance and progression suggests that immunotherapy may represent a valuable strategy towards the control and eradication of these malignancies. Despite initial successes of anti-idiotype vaccination, its clinical benefits have not been definitely proven. New insights into the …

    the-open-u Download PDF for Active and Adoptive Immunotherapy in Indolent Lymphoproliferative Diseases (opens in a new tab)

  7. Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity

    … than 15 years old. Recently, the addition of passive immunotherapy with the anti-GD2 antibody ch14.18 provided a clinical benefit with a 20% improvement in 2-year prevention of relapse for children with high-risk disease. However, still one third of the patients die from their disease …

    fu-berlin Repository record for Fenretinide sensitizes multidrug-resistant human neuroblastoma cells to antibody-independent and ch14.18-mediated NK cell cytotoxicity (opens in a new tab)

  8. Fc-Dependent Antibody-Mediated Functions Against HIV-1

    … with implications for HIV-1 vaccine and passive immunotherapy strategies, and broader relevance also for other infectious diseases as well as antibody-based cancer immunotherapy.</p>

    duke Repository record for Fc-Dependent Antibody-Mediated Functions Against HIV-1 (opens in a new tab)

  9. Designing Synthetic Dna Encoded Immunotherapeutics And Nanoparticle Vaccines For Enhanced Immunity-Mediated Protection

    … immunizations require immune-competent hosts, passive immunotherapy can be a complementary treatment in which protective biologics are directly administered for more immediate protection. However, GMP production of both vaccines and immuno-therapies can be costly and time-consuming, impeding …

    penn Repository record for Designing Synthetic Dna Encoded Immunotherapeutics And Nanoparticle Vaccines For Enhanced Immunity-Mediated Protection (opens in a new tab)

  10. Magnetic Resonance Imaging in the Assessment of Anti Prion Mediated Neurotoxicity In Vivo

    … neurotoxic side effects of antiprion antibodies, passive immunotherapy with these ligands is still a therapeutic strategy under investigation in the treatment of TSE. Using my established MRI based quantification system and basic histological methods, I assessed the neurotoxic potential of the …

    zurich

  11. Life of Tau: Oligomerization, CNS Extracellular Clearance and Role as Plasma Biomarker

    … has made it an attractive therapeutic target. Passive immunotherapy with monoclonal antibodies has shown promise and is being tested in clinical trials in humans. Vaccination trials are also underway. In addition, other approaches such as antisense oligonucleotides (ASOs) and small molecule …

    wustl Repository record for Life of Tau: Oligomerization, CNS Extracellular Clearance and Role as Plasma Biomarker (opens in a new tab)

  12. Effects of Monoclonal Anti-Abeta Antibodies on the Amyloid Beta Peptide Fibrillogenesis and their Involvement in the Clearance of Alzheimer's Disease Plaques

    Alzheimer’s disease (AD) is the most common cause of senile dementia worldwide. AD is a neurodegenerative disorder characterized by the loss of memory and language skill, collapse of the cognitive function, and distortion of social behavior. As of today, the onset mechanisms of AD and cure are …

    usf Repository record for Effects of Monoclonal Anti-Abeta Antibodies on the Amyloid Beta Peptide Fibrillogenesis and their Involvement in the Clearance of Alzheimer's Disease Plaques (opens in a new tab)